Abbott DBS Post-Market Study of Outcomes for Indications Over Time
NCT04071847
This study is recruiting at 8 US sites in 7 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this international study is to evaluate long-term safety and effectiveness of Abbott deep brain stimulation (DBS) systems for all indications, including Parkinson's disease, essential tremor or other disabling tremor and dystonia.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Movement Disorders
- Parkinson Disease
- Essential Tremor
- Tremor
- Dystonia
- Primary Dystonia
- Secondary Dystonia
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- Any age
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Abbott Medical Devices
- Last updated on ClinicalTrials.gov
- January 8, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 1
- University of South Florida - Department of Neurology · Tampa, FL
Illinois · 1
- Rush University Medical Center · Chicago, IL
Indiana · 1
- Indiana University · Indianapolis, IN
Kentucky · 1
- University of Louisville · Louisville, KY
New York · 1
- Albany Medical Center · Albany, NY
Ohio · 2
- The Cleveland Clinic Foundation · Cleveland, OH
- Ohio State Medical · Columbus, OH
Utah · 1
- University of Utah Hospital · Salt Lake City, UT
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.